Regulatory effect of indoleamine 2,3-dioxygenase on immune system

Chinese Pharmacological Bulletin

Volumn 22, Issue 11, 2006, Pages 1296-1299

  Fu, Yun Feng ^a   Ren, Yong Xin ^a   Yang, Yi Fu ^a   Zuo, Jian Ping ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Cell immune; Indoleamine 2, 3 dioxygenase; Tryptophan

Indexed keywords

DRUG METABOLITE; INDOLEAMINE 2,3 DIOXYGENASE; TRYPTOPHAN;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CANCER; CELL CLONE; CELL PROLIFERATION; DENDRITIC CELL; DRUG EFFECT; ENZYME DEGRADATION; GRAFT REJECTION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; MACROPHAGE; MICROENVIRONMENT; PROTEIN DEPLETION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RISK FACTOR;

EID: 33847040812     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Munn D H, Zhou M, Attwood J T, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism[J]. Science, 1998, 281 (5380): 1191-3.
2. Mellor A L, Munn D H. IDO expression by dendritic cells: tolerance and tryptophan catabolism [J]. Nat Rev Immunol, 2004, 4 (10):762-74.
3. Wirleitner B, Neurauter G, Schrocksnadel K, et al. Interferon-gamma- induced conversion of tryptophan: immunologic and neuropsychiatric aspects[J]. Curr Med Che, 2003, 10(16): 1581-91.
4. Widner B, Werner E R, Schennach H, et al. Simultaneous measurement of serum tryptophan and kynurenine by HPLC [J]. Clin Chem, 1997, 43(12): 2424-6.
5. Fallarino F, Vacca C, Orabona C, et al. Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells[J]. Int Immunol, 2002,14(1): 65-8.
6. Munn D H, Sharma M D, Lee J R, et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase [J]. Science, 2002,297(5588):1867-70.
7. Munn D H, Shafizadeh E, Attwood J T, et al. Inhibition of T cell proliferation by macrophage tryptophan catabolism [J]. J Exp Med, 1999, 189(9):1363-72.
8. Mellor A L, Keskin D B, Johnson T, et al. Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses [J]. J Immunol, 2002, 168(8): 3771-6.
9. Mellor A L, Munn D H. Tryptophan catabolism and regulation of adaptive immunity[J]. J Immunol, 2003, 170(12): 5809-13.
10. Lee G K, Park H J, Macleod M, et al. Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division [J]. Immunology, 2002, 107(4): 452-60.
11. Fallarino F, Grohmann U, Vacca C, et al. T cell apoptosis by tryptophan catabolism[J]. Cell Death Differ, 2002, 9(10): 1069 -77.
12. Grohmann U, Orabona C, Fallarino F, et al. CTLA-4-Ig regulates tryptophan catabolism in vivo [J]. Nat Immunol, 2002, 3(11): 1097-101.
13. Mellor A L, Baban B, Chandler P, et al. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion [J]. J Immunol, 2003, 171 (4): 1652-5.
14. Kwidzinski E, Bunse J, Aktas O, et al. Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation[J]. FASEB J, 2005, 19(10):1347-9.
15. Platten M, Ho P P, Youssef S, et al. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite [J]. Science, 2005, 310(5749): 850-5.
16. Miki T, Sun H, Lee Y, et al. Blockade of tryptophan catabolism prevents spontaneous tolerogenieity of liver allografts [J]. Transplant Proc, 2001, 33(1-2):129-30.
17. Bauer T M, Jiga L P, Chuang J J, et al. Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo [J]. Transpl Int, 2005,18(1): 95-100.
18. Sakurai K, Zou J P, Torres N I, et al. Study of the effect of indoleamine 2,3-dioxygenase on murine mixed lymphocyte reactions and skin allograft rejection[J]. Transplant Proc, 2002, 34(8): 3271-3.
19. Li Y, Tredget E E, Ghaffari A, et al. Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute[J]. J Invest Dermatol, 2006, 126(1): 128-36.
20. Beutelspacher S C, Pillai R, Watson M P, et al. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression [J]. Eur J Immunol, 2006, 36(3): 690-700.
21. Liu H, Liu L, Fletcher B S, et al. Novel action of indoleamine 2, 3-dioxygenase attenuating acute lung allograft injury [J]. Am J Respir Crit Care Med,2006,173(5): 566-72.
22. Alexander A M, Crawford M, Bertera S, et al. Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes [J]. Diabetes, 2002, 51(2): 356-65.
23. Uyttenhove C, Pilotte L, Theate I, et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase[ J]. Nat Med, 2003, 9(10): 1269 -74.
24. Friberg M, Jennings R, Alsarraj M, et al. Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection[J]. Int J Cancer, 2002, 101(2): 151-5.
25. Muller A J, DuHadaway J B, Donover P S, et al. Inhibition of indoleamine 2, 3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy [J]. Nat Med, 2005, 11(3):312-9.